DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.66−0.01 (-0.10%)
Close on Nov 11, 2026Market cap $520.92MP/E –Yield –
DiaMedica Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
DiaMedica Therapeutics's enterprise value was $477.42M on Nov 11, 2026, against $394.13M a year earlier. Over the last 5 years it ranged from -$7.20M to $477.42M, with a median of $82.42M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $477.42M | +32.9% |
| 2025 | Dec 31, 2025 | $359.24M | +97.4% |
| 2024 | Dec 31, 2024 | $182.02M | +252.8% |
| 2023 | Dec 29, 2023 | $51.59M | +807.8% |
| 2022 | Dec 30, 2022 | $5.68M | -93.1% |
| 2021 | Dec 31, 2021 | $82.42M | -54.3% |
| 2020 | Dec 31, 2020 | $180.21M | +271.6% |
| 2019 | Dec 31, 2019 | $48.49M | +182.2% |
| 2018 | Dec 31, 2018 | $17.19M | – |
See a number that looks wrong?